Share on StockTwits

Acadia Healthcare Company (NASDAQ:ACHC)‘s stock had its “outperform” rating restated by equities researchers at Raymond James in a research report issued on Wednesday. They currently have a $55.00 price target on the stock, up from their previous price target of $49.00. Raymond James’ target price would suggest a potential upside of 14.63% from the company’s current price.

Separately, analysts at Ned Davis Research upgraded shares of Acadia Healthcare Company from a “sell” rating to a “neutral” rating in a research note on Monday, April 21st. Five research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $52.36.

Shares of Acadia Healthcare Company (NASDAQ:ACHC) traded up 0.06% during mid-day trading on Wednesday, hitting $48.01. 212,432 shares of the company’s stock traded hands. Acadia Healthcare Company has a 1-year low of $30.70 and a 1-year high of $53.87. The stock’s 50-day moving average is $42.59 and its 200-day moving average is $46.57. The company has a market cap of $2.438 billion and a P/E ratio of 46.45.

Acadia Healthcare Company (NASDAQ:ACHC) last announced its earnings results on Tuesday, April 29th. The company reported $0.28 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.28. The company had revenue of $206.10 million for the quarter, compared to the consensus estimate of $194.83 million. The company’s quarterly revenue was up 24.4% on a year-over-year basis. On average, analysts predict that Acadia Healthcare Company will post $1.30 earnings per share for the current fiscal year.

Acadia Healthcare Company, Inc is a provider of inpatient behavioral healthcare services in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.